Related references
Note: Only part of the references are listed.Childhood Socioeconomic Disadvantage and Risk of Fatty Liver in Adulthood: The Cardiovascular Risk in Young Finns Study
Tomi T. Laitinen et al.
HEPATOLOGY (2020)
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison et al.
JOURNAL OF HEPATOLOGY (2020)
Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices
Zobair M. Younossi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported Outcomes
Zobair M. Younossi et al.
HEPATOLOGY COMMUNICATIONS (2020)
Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States
Zobair M. Younossi et al.
HEPATOLOGY (2019)
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Zobair Younossi et al.
HEPATOLOGY (2019)
Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Peter J. Eddowes et al.
GASTROENTEROLOGY (2019)
Agreement between retrospectively assessed health-related quality of life collected 1week and 12months post-injury: an observational follow-up study
Juanita Haagsma et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2019)
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials
Quentin M. Anstee et al.
HEPATOLOGY (2019)
Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation
Yvonne Huber et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Non-alcoholic fatty liver disease - A global public health perspective
Zobair M. Younossi
JOURNAL OF HEPATOLOGY (2019)
Derivation and Performance of Standardized Enhanced Liver Fibrosis (ELF) Test Thresholds for the Detection and Prognosis of Liver Fibrosis
James Day et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Chris Estes et al.
HEPATOLOGY (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Zobair M. Younossi et al.
CLINICS IN LIVER DISEASE (2018)
Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis
Stephen A. Harrison et al.
GASTROENTEROLOGY (2018)
Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib
Zobair M. Younossi et al.
LIVER INTERNATIONAL (2018)
Patient-Reported Outcomes and the Economic Effects of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: The Value Proposition
Zobair M. Younossi
HEPATOLOGY (2018)
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
Stuart McPherson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Minimal important difference to infer changes in health-related quality of life-a systematic review
Ravishankar Jayadevappa et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2017)
A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD
Zobair M. Younossi et al.
LIVER INTERNATIONAL (2017)
NAFLD PNPLA3 and obesity: a synergistic relationship in NAFLD
Jake P. Mann et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States
Michael H. Le et al.
PLOS ONE (2017)
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference
M. Munteanu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
Stuart McPherson et al.
JOURNAL OF HEPATOLOGY (2015)
Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease
Zobair M. Younossi et al.
PHARMACOECONOMICS (2015)
The Performance of Enhanced Liver Fibrosis (ELF) Test for the Staging of Liver Fibrosis: A Meta-Analysis
Qingsong Xie et al.
PLOS ONE (2014)
Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets
Ben van Hout et al.
VALUE IN HEALTH (2012)
Clinical applications of transient elastography
Kyu Sik Jung et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2012)
Modelling SF-6D health state preference data using a nonparametric Bayesian method
Sarner A. Kharroubi et al.
JOURNAL OF HEALTH ECONOMICS (2007)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling et al.
HEPATOLOGY (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
CT Wai et al.
HEPATOLOGY (2003)
Share Paper
